CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Dr. Thomas Hughes, Ph.D., president and chief executive officer, will present a company overview at several upcoming conferences.
